Company facts
- Headquarters
- Durham, North Carolina
- Most recent report
- 8-K, filed Oct 30, 2026
- Incorporated
- Nevada
- Filings on record
- 253 filings
- On EDGAR
- CIK 1919246
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 12
News 8 of 35
- 8-K Leadership change Oct 30, 2026
- 8-K Leadership change Oct 1, 2026
- 8-K Quarterly results Aug 13, 2026
- 8-K Current report on a material event Aug 13, 2026
- 8-K Current report on a material event May 28, 2026
- 8-K Leadership change May 21, 2026
- 8-K Quarterly results May 14, 2026
- 8-K Current report on a material event Apr 14, 2026
Prospectuses and Registrations 8 of 43
- 424B3 Prospectus supplement for an offering Feb 13, 2026
- S-3 Shelf registration statement Feb 2, 2026
- 424B3 Prospectus supplement for an offering Sep 29, 2025
- S-3/A Shelf registration statement, amended Sep 19, 2025
- S-3 Shelf registration statement Aug 28, 2025
- S-8 Registration statement for an employee plan Jul 25, 2025
- POS AM Post-effective amendment to a registration Dec 11, 2024
- POS AM Post-effective amendment to a registration Nov 22, 2024
Proxies 7
- DEFA14A Extra proxy material Aug 18, 2026
- DEF 14A Proxy statement for a shareholder vote Aug 18, 2026
- PRE 14A Preliminary proxy statement Aug 7, 2026
- DEF 14A Proxy statement for a shareholder vote Nov 25, 2025
- PRE 14A Preliminary proxy statement Nov 14, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 26, 2024
- PRE 14A Preliminary proxy statement Sep 9, 2024
Ownership 8 of 103
- SCHEDULE 13D/A Large holder reported an active stake, amended Nov 3, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jun 17, 2026
Other 8 of 53
Everything here comes from Pelthos Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.